Next Article in Journal
Natural Compounds with Potential to Modulate Cancer Therapies and Self-Reactive Immune Cells
Next Article in Special Issue
Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis
Previous Article in Journal
Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma
Previous Article in Special Issue
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma
 
 
Review

Article Versions Notes

Cancers 2020, 12(3), 671; https://doi.org/10.3390/cancers12030671
Action Date Notes Link
article xml file uploaded 13 March 2020 11:43 CET Original file -
article pdf uploaded. 13 March 2020 11:43 CET Version of Record https://www.mdpi.com/2072-6694/12/3/671/pdf-vor
article supplementary file uploaded. 13 March 2020 11:43 CET - https://www.mdpi.com/2072-6694/12/3/671#supplementary
article xml file uploaded 27 March 2020 09:10 CET Update -
article xml uploaded. 27 March 2020 09:10 CET Update https://www.mdpi.com/2072-6694/12/3/671/xml
article pdf uploaded. 27 March 2020 09:10 CET Updated version of record https://www.mdpi.com/2072-6694/12/3/671/pdf
article html file updated 27 March 2020 09:12 CET Original file -
article html file updated 2 April 2020 06:20 CEST Update -
article html file updated 20 July 2022 22:49 CEST Update https://www.mdpi.com/2072-6694/12/3/671/html
Back to TopTop